Innospec Inc. $IOSP Stake Boosted by ZWJ Investment Counsel Inc.

ZWJ Investment Counsel Inc. lifted its stake in shares of Innospec Inc. (NASDAQ:IOSP) by 5.9% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 114,933 shares of the specialty chemicals company’s stock after buying an additional 6,431 shares during the quarter. ZWJ Investment Counsel Inc. owned approximately 0.47% of Innospec worth $10,955,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. BlackRock Inc. acquired a new stake in Innospec in the second quarter valued at approximately $356,596,000. Western Standard LLC purchased a new stake in shares of Innospec in the 2nd quarter valued at approximately $19,276,000. Hsbc Holdings PLC purchased a new stake in shares of Innospec in the 2nd quarter valued at approximately $1,936,000. Arrowstreet Capital Limited Partnership increased its position in shares of Innospec by 196.5% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 18,497 shares of the specialty chemicals company’s stock valued at $1,351,000 after purchasing an additional 12,259 shares during the last quarter. Finally, The Manufacturers Life Insurance Company acquired a new stake in shares of Innospec in the 2nd quarter valued at $982,000. 96.64% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

IOSP has been the subject of several recent analyst reports. Weiss Ratings raised shares of Innospec from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, October 8th. Wall Street Zen cut Innospec from a “strong-buy” rating to a “buy” rating in a research note on Saturday, September 26th. Finally, Seaport Research Partners restated a “buy” rating and issued a $110.00 price target on shares of Innospec in a research note on Thursday, August 6th. Two equities research analysts have rated the stock with a Hold rating. According to data from MarketBeat, Innospec has a consensus rating of “Hold”.

Innospec Price Performance

Shares of IOSP opened at $97.10 on Thursday. Innospec Inc. has a 1-year low of $65.51 and a 1-year high of $100.48. The stock has a market cap of $2.39 billion, a PE ratio of 19.82, a price-to-earnings-growth ratio of 2.58 and a beta of 0.90. The firm has a fifty day moving average price of $94.66 and a 200 day moving average price of $85.41.

Innospec (NASDAQ:IOSP) last issued its quarterly earnings data on Tuesday, August 4th. The specialty chemicals company reported $1.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.05 by $0.22. Innospec had a return on equity of 9.22% and a net margin of 6.60%. The company had revenue of $491.40 million for the quarter, compared to analyst estimates of $457.25 million. During the same quarter last year, the company posted $1.26 earnings per share. The business’s quarterly revenue was up 11.8% compared to the same quarter last year. As a group, equities analysts expect that Innospec Inc. will post 5.03 EPS for the current fiscal year.

Innospec Company Profile

Innospec Inc (NASDAQ: IOSP) is a global specialty chemicals company that develops, manufactures and supplies products for the energy, transportation, personal care and industrial markets. Its offerings are designed to improve fuel performance, support industrial processes and enhance the properties of a wide range of consumer and commercial products.

The company operates through businesses focused on fuel specialties, performance chemicals and oilfield services. Its products include fuel additives, surfactants, specialty polymers and other performance chemicals used in fuel and refinery applications, home and personal care products, agriculture, construction, mining and industrial manufacturing.